1. Home
  2. RYAAY vs IQV Comparison

RYAAY vs IQV Comparison

Compare RYAAY & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ryanair Holdings plc

RYAAY

Ryanair Holdings plc

HOLD

Current Price

$55.99

Market Cap

30.7B

ML Signal

HOLD

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$181.17

Market Cap

28.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RYAAY
IQV
Founded
1985
1982
Country
Ireland
United States
Employees
25952
93000
Industry
Air Freight/Delivery Services
Biotechnology: Commercial Physical & Biological Resarch
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.7B
28.6B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
RYAAY
IQV
Price
$55.99
$181.17
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
16
Target Price
$78.00
$227.13
AVG Volume (30 Days)
1.4M
1.5M
Earning Date
05-18-2026
05-05-2026
Dividend Yield
1.54%
N/A
EPS Growth
N/A
4.67
EPS
N/A
1.61
Revenue
N/A
$9,739,000,000.00
Revenue This Year
$11.99
$6.77
Revenue Next Year
$6.32
$5.89
P/E Ratio
$12.60
$115.68
Revenue Growth
N/A
41.60
52 Week Low
$53.14
$153.23
52 Week High
$74.24
$247.05

Technical Indicators

Market Signals
Indicator
RYAAY
IQV
Relative Strength Index (RSI) 44.04 54.12
Support Level $55.43 $176.99
Resistance Level $61.70 $182.20
Average True Range (ATR) 1.43 7.00
MACD -0.22 0.73
Stochastic Oscillator 2.52 65.45

Price Performance

Historical Comparison
RYAAY
IQV

About RYAAY Ryanair Holdings plc

Ryanair is Europe's largest low-cost airline, known for its extensive network and highly efficient business model. Operating over 3,600 flights daily across 240-plus destinations in 40 countries, Ryanair has built its success on offering affordable air travel while maintaining tight control over costs. The airline primarily uses Boeing 737 aircraft, including the newer 737 8-200 "Gamechanger" variant, which simplifies operations and reduces expenses. Ryanair focuses on high passenger volume, ancillary revenue, and operational efficiency, ensuring its position as a leading airline in Europe.

About IQV IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its reserach and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

Share on Social Networks: